Author

Vendela Rissler

Danish Cancer Society

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Approach:experimental assay· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

Carl SandéniD· 1 shared Christina Orsmark‐PietrasiD· 1 shared Elena PapaleoiD· 1 shared Gunnar JuliussoniD· 1 shared Hanna ThorssoniD· 1 shared Helena ÅgerstamiD· 1 shared Henrik LilljebjörniD· 1 shared Jonathan DespondsiD· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Carl SandénORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The cellular state space of AML unveils novel NPM1 subtypes with distinct clinical outcomes and immune evasion properties

Henrik Lilljebjörn, Pablo Peña‐Martínez, Hanna Thorsson, Rasmus Henningsson, Marianne Rissler, Niklas Landberg, Noelia Puente‐Moncada, Sofia von Palffy, Vendela Rissler, Petr Staněk, Jonathan Desponds, Xiangfu Zhong, Gunnar Juliusson, Vladimir Lazarević, Sören Lehmann, , Thoas Fioretos

This study uses single-cell RNA sequencing to identify novel NPM1 subtypes in AML with distinct clinical outcomes and immune evasion properties.

bioRxiv · Feb 12, 2025 · PreprintCancer Biology

Alterations of the pro-survival Bcl-2 protein interactome in breast cancer at the transcriptional, mutational and structural level

Simon Mathis Kønig, Vendela Rissler, Thilde Terkelsen, Matteo Lambrughi, Elena Papaleo

The paper analyzes the transcriptomic, mutational, and structural alterations of pro-survival Bcl-2 proteins in breast cancer to identify potential therapeutic targets.

bioRxiv · Jul 12, 2019 · PreprintBioinformatics